Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics.
Gao Y, Kabotyanski EB, Shepherd JH, Villegas E, Acosta D, Hamor C, Sun T, Montmeyor-Garcia C, He X, Dobrolecki LE, Westbrook TF, Lewis MT, Hilsenbeck SG, Zhang XH, Perou CM, Rosen JM. Gao Y, et al. Among authors: villegas e. Cancer Res Commun. 2021 Dec;1(3):178-193. doi: 10.1158/2767-9764.crc-21-0106. Epub 2021 Dec 27. Cancer Res Commun. 2021. PMID: 35156101 Free PMC article.
Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Non-Muscle-Invasive Bladder Cancer.
Villegas E, Lajkosz K, Din S, Kuk C, Chan A, Kwong JCC, Vitug C, Gao B, Hemminki O, Kot D, Misurka J, Black P, Jewett M, Soloway MS, Roupret M, Compérat E, Sweet J, Seisen T, Fleshner NE, Wrana J, van der Kwast TH, Kulkarni GS, Zlotta AR. Villegas E, et al. J Urol. 2024 Oct 29:101097JU0000000000004305. doi: 10.1097/JU.0000000000004305. Online ahead of print. J Urol. 2024. PMID: 39470318
Expression and characterization of scFv-6009FV in Pichia pastoris with improved ability to neutralize the neurotoxin Cn2 from Centruroides noxius.
Adame M, Vázquez H, Juárez-López D, Corzo G, Amezcua M, López D, González Z, Schcolnik-Cabrera A, Morales-Martínez A, Villegas E. Adame M, et al. Among authors: villegas e. Int J Biol Macromol. 2024 Aug;275(Pt 1):133461. doi: 10.1016/j.ijbiomac.2024.133461. Epub 2024 Jun 28. Int J Biol Macromol. 2024. PMID: 38945343
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer.
Park KH, Loibl S, Sohn J, Park YH, Jiang Z, Tadjoedin H, Nag S, Saji S, Md Yusof M, Villegas EMB, Lim EH, Lu YS, Ithimakin S, Tseng LM, Dejthevaporn T, Chen TW, Lee SC, Galvez C, Malwinder S, Kogawa T, Bajpai J, Brahma B, Wang S, Curigliano G, Yoshino T, Kim SB, Pentheroudakis G, Im SA, Andre F, Ahn JB, Harbeck N. Park KH, et al. Among authors: villegas emb. ESMO Open. 2024 May;9(5):102974. doi: 10.1016/j.esmoop.2024.102974. Epub 2024 Apr 12. ESMO Open. 2024. PMID: 38796284 Free PMC article.
National expert consensus on home-administered oncologic therapies in Spain.
Villegas E, Arruñada M, Casado MÁ, González S, Moreno-Martínez ME, Peñuelas MÁ, Torres AM, Sierra Y, Seguí MA. Villegas E, et al. Front Oncol. 2024 Feb 16;14:1335344. doi: 10.3389/fonc.2024.1335344. eCollection 2024. Front Oncol. 2024. PMID: 38434688 Free PMC article.
210 results